Blood clotting test for patients on blood thinners
Part of Blood & lymphatic clinical trials.
This study measures how long it takes for your blood to clot while you are taking anticoagulant medication. The purpose is to understand typical clotting times for patients on these drugs, which may help improve future monitoring or treatment decisions.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 80 years old.
- You have been taking your prescribed blood thinner regularly for at least one month.
- You do not have a personal or family history of bleeding or clotting disorders.
- Your weight is under 265 pounds and your BMI is 40 or less.
- You do not have kidney or liver problems.
- You have not had a stomach ulcer or gastrointestinal bleeding in the last 6 months.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This hospital study looks at blood and clotting (coagulation) measurements in people who arrive with specific types of stroke or brain bleeding not caused by injury. It may help doctors better understand clotting changes after these events and improve care decisions.
This study tests a new blood test called ClotChek™ to see how well it works for people taking direct oral anticoagulants (DOACs), a type of blood thinner. You would give a blood sample, and the test may help doctors better monitor your medication.
This study looks at a special blood test (clot waveform analysis) to see if it can help doctors better understand why some people have a prolonged clotting time. This might help them find the cause more quickly and accurately.
This trial tests a new lab device that measures how well your body forms primary blood clots while blood is kept in flowing conditions. It may help doctors better assess bleeding or clotting tendencies and guide future care.
This trial uses stored blood samples to see how well different lab tests measure clotting when someone has a factor deficiency (like low levels of clotting proteins) or liver damage. It may help doctors choose the most accurate test for these situations.
This study looks at how the body stops bleeding or forms clots in people with bleeding or clotting disorders. It may help researchers understand these conditions better and improve evaluation tests.
Hear when a new Blood Coagulation Disorder trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.